A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review
Annals of Hematology · 2025
DOI: 10.1007/s00277-025-06364-4 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Hematology, 2025. Verfasst von Yu Jiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Hospital of China Medical University, 155 Nanjing North Street, Shenyang, Liaoning, 110000, China. Hauptthemen laut MEDLINE: Factor VII, Factor VII Deficiency, Heterozygote, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology of Liaoning Province.
Abstract (Originalsprache)
Congenital factor VII (FVII) deficiency is a rare autosomal recessive bleeding disorder characterized by prolonged prothrombin time (PT) and reduced FVII coagulant activity (FVII: C). Here, we present the case of a middle-aged male patient with gastrointestinal bleeding, who exhibited prolonged PT and decreased FVII: C levels. Gene sequencing analysis revealed compound heterozygous mutations in the F7 gene: c.64G > A (p.V22I) and c.506-1G > A. Based on the laboratory results and gene sequencing, the patient was diagnosed as FVII deficiency. After adding recombinant activated FVII (rFVIIa) for several days, the laboratory indicators returned to normal and the bleeding symptoms were relieved. In subsequent validation studies, we also identified the c.506-1G > A mutation in his older sister and daughter. Importantly, this represents the first documented case where both mutations coexist concurrently. Additionally, our literature review reveals that approximately 50% of mutation types associated with congenital FVII deficiency are located on exon 9; however, there is no significant correlation between the reduction in FVII: C levels and severity of clinical symptoms based on EAHAD database analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Hospital of China Medical University, 155 Nanjing North Street, Shenyang, Liaoning, 110000, China.
- Department of Hematology, The First Hospital of China Medical University, 155 Nanjing North Street, Shenyang, Liaoning, 110000, China. yanxiaojing_pp@hotmail.com.
Förderung
- Department of Science and Technology of Liaoning Province
Zitieren
APA
Jiao, Y., Lv, X., & Yan, X. (2025). A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review. Annals of Hematology. https://doi.org/10.1007/s00277-025-06364-4
Vancouver
Jiao Y, Lv X, Yan X. A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review. Annals of Hematology. 2025. doi:10.1007/s00277-025-06364-4
BibTeX
@article{Jiao2025,
author = {Jiao, Yu and Lv, Xiaoyi and Yan, Xiaojing},
title = {A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-025-06364-4}
}
EUVIMED